• 5th Floor. Amrita Tower, KPCC Junction, MG Road Kochi

News and Media Coverage

PNB Vesper announces its successful competition of phase-2 trials of GPP-Baladol in Covid patients

PNB Vesper, a leading Kerala based Life Sciences Company, today announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. PNB Vesper, a Kerala based Life Science Company has successfully … Continued

READ MORE
PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients

PNB Vesper, a Kerala-based life sciences company, announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. The company had received approval from the Drug Controller General of India (DCGI) … Continued

READ MORE
Indian firm PNB Vesper completes Phase II Covid-19 drug trials

India-based life sciences company PNB Vesper has reportedly completed the Phase II clinical trials of its proprietary drug, PNB-001 (GPP-Baladol), on Covid-19 patients. In all the initial preclinical studies, the drug has demonstrated positive results, IANS reported. In addition, it … Continued

READ MORE
Life sciences firm PNB Vesper successfully completes Phase 2 trials of Covid-19 drug

PNB Vesper, a leading Kerala-based life sciences company, on Thursday announced that it has successfully completed the Phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on Covid-19 patients. The company had received approval from the Drug Controller General … Continued

READ MORE
PNB Vesper Obtains Permission to Test its New Chemical Entity PNB 001 in COVID-19 Patients

PNB Vesper life science Pvt Ltd, is a leading Indian Pharma Research company with a vision to “work towards a healthier World by developing novel, safe, and affordable medicines to prevent and treat unmet medical needs”. PNB Vesper has today … Continued

READ MORE
PNB Vesper Life Sciences’ ‘new chemical entity’ okayed for mid-stage Covid-19 trial

In a potentially significant development for the pharmaceutical industry, a new drug developed by a Kochi-based firm has been given the green light to move to mid-stage trials on Covid-19 patients. If proven effective, the drug, GPP-Baladol, would be the … Continued

READ MORE
Indian Pharma company gets DCGI nod for human trial of new COVID-19 drug, Baladol

Amid the raging coronavirus pandemic, PNB Vesper Life Science Private Limited on Friday received approval from the Drug Controller General of India to conduct the clinical trial of their drug on COVID-19 patients. Speaking to IANS about the breakthrough innovation, … Continued

READ MORE
Kochi-based firm gets nod to start clinical trial of Covid drug

PNB Vesper Life Science Pvt Ltd, a Kochi-based pharma research company, has received approval from the Drugs Controller General of India (DCGI) to conduct the Phase 2b clinical trial of its proprietary drug PNB-0001, named GPP-Baladol, among Covid-19 patients.PNB Vesper … Continued

READ MORE
Kochi firm gets nod to test its drug on Covid-19 patients

received approval from the Drug Controller General of India (DCGI) to conduct the Phase 2b clinical trial of their propriety drug PNB-001 (GPP-Baladol) in treating Covid-19 patients. PNB 001 may be the first new chemical entity in the world for … Continued

READ MORE
1 2 3